Related Experiment Video

Updated: Aug 17, 2026

Multiomics Analysis of TMEM200A as a Pan-Cancer Biomarker
07:47

Multiomics Analysis of TMEM200A as a Pan-Cancer Biomarker

Published on: September 15, 2023

A role for ADAM12 in breast tumor progression and stromal cell apoptosis

Marie Kveiborg1, Camilla Fröhlich, Reidar Albrechtsen

  • 1Institute of Molecular Pathology, University of Copenhagen, Denmark.

Cancer Research
|June 3, 2005
PubMed

Insights

ADAM12, a protein found in breast cancer, promotes tumor growth by affecting cell death. It makes tumor cells resistant to apoptosis while increasing cancer-associated stromal cell death.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • Cell survival is crucial in cancer development and progression.
  • Tumor resistance to programmed cell death is a key area of research.
  • Stromal fibroblasts play a significant role in tumor initiation and progression.

Purpose of the Study:

  • To investigate the role of ADAM12 in human breast carcinoma.
  • To determine how ADAM12 influences tumor cell and stromal cell apoptosis.
  • To elucidate the mechanisms by which ADAM12 affects tumor progression.

Main Methods:

  • Analysis of stromal cell apoptosis in human breast carcinoma and nonmalignant breast lesions.
  • Utilizing a mouse breast cancer model to study the effect of ADAM12 on tumor progression.
  • Assessing the impact of ADAM12 on tumor cell proliferation and apoptosis.
  • Evaluating the in vitro apoptotic sensitivity of nonneoplastic and tumor cells in the presence of ADAM12.

Main Results:

  • Stromal cell apoptosis is observed in human breast carcinoma but not in nonmalignant breast lesions.
  • ADAM12, upregulated in breast cancer, accelerates tumor progression in a mouse model.
  • ADAM12 does not affect tumor cell proliferation but decreases tumor cell apoptosis and increases stromal cell apoptosis.
  • ADAM12 increases the apoptotic sensitivity of nonneoplastic cells in vitro while making tumor cells more resistant to apoptosis.

Conclusions:

  • ADAM12 plays a dual role in regulating cell survival, impacting both tumor and stromal cells.
  • The modulation of apoptosis by ADAM12 contributes to breast cancer progression.
  • ADAM12 represents a potential therapeutic target for breast cancer treatment.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...